Taipei, Taiwan

Jin-Ding Huang

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Jin-Ding Huang

Introduction

Jin-Ding Huang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended-release medications. With a total of four patents to his name, Huang's work is recognized for its innovative approaches to drug delivery systems.

Latest Patents

Huang's latest patents focus on pharmaceutical formulations for the sustained release of sebacoyl dinalbuphine ester. These inventions relate to injectable, extended-release pharmaceutical formulations that comprise a nalbuphine ester prodrug homogenously dissolved in a solution containing a pharmaceutically acceptable oil and an oil-miscible retaining solvent. The patents also detail manufacturing processes and medical uses of these formulations. Furthermore, the inventions provide methods for adjusting the duration of action by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Career Highlights

Throughout his career, Jin-Ding Huang has worked with prominent companies in the pharmaceutical industry, including Lumosa Therapeutics Co., Ltd and Shanghai Lumosa Therapeutics Co., Ltd. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Huang has collaborated with several professionals in his field, including Chan-Jung Li and David Chih-Kuang Chou. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical technology.

Conclusion

Jin-Ding Huang's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in the development of effective drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…